Provided by Tiger Trade Technology Pte. Ltd.

Whitehawk Therapeutics, Inc.

4.70
-0.0270-0.57%
Volume:5K
Turnover:25.34K
Market Cap:268.11M
PE:-4.22
High:4.77
Open:4.74
Low:4.61
Close:4.73
52wk High:5.50
52wk Low:1.70
Shares:57.01M
Float Shares:28.74M
Volume Ratio:0.71
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1137
EPS(LYR):-0.3328
ROE:-44.98%
ROA:-28.70%
PB:1.47
PE(LYR):-14.13

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jun 12, 2026

Major Issues Report

Form 8-K - Current report
May 21, 2026

Major Issues Report

Form 8-K - Current report
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
Apr 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 13, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report